UNIC Athens launches the “UNIC Athens Pharmacy Insights Series”, a new initiative highlighting key developments, emerging trends, and expert perspectives in pharmaceutical science, clinical pharmacy, applied research, and regulatory affairs. The series brings together leading academics, clinical researchers, and industry professionals to explore critical topics shaping the future of medicinal product development, regulation, clinical practice, and real-world use.

The inaugural event, entitled “Drug Regulation in Focus: CNS Products, Bioequivalence, Biowaivers and Emerging Guidelines”, will be held on 20 May 2026, from 17:30 to 19:30, at UNIC Athens, Amphitheatre A1. It will focus specifically on regulatory updates in CNS clinical evaluation and advances in Bioequivalence and Biowaivers concerning generic products, providing a cohesive overview of guideline changes impacting medicine development and their approval.

Speakers

Dr Georgios Aislaitner, Clinical Assessor, German Federal Institute for Drugs and Medical Devices (BfArM).

Lecture Topic: Recent Developments in the Regulation of CNS Medicinal Products.

———

Dr Marcus Savsek, Senior Regulatory Affairs Specialist, German Federal Institute for Drugs and Medical Devices (BfArM).

Lecture Topic: Bioequivalence and Biowaivers: Current Guidelines and Regulatory Perspectives.